Service lines
Every channel runs through the same SOC2-audited documentation layer, the same licensed pharmacist review and the same GDP-grade shipping pipeline.
Single-patient requests for therapies that aren't approved, commercially available, or temporarily out of stock in the requesting country — handled under named-patient import statutes with full paper trails.
Open a procurement fileTie-ups with WHO-GMP, US-FDA and EU-GMP inspected sites for generics, biologics and vaccines — with the audit reports attached, not promised.
Open a procurement fileComparator sourcing, rescue-medicine supply, co-medications and IMP movement with expiry-tracking, IRT integration and on-site reconciliation at investigator sites.
Open a procurement fileOrphan therapies routed through compassionate-use, named-patient and parallel-import pathways — for the 7,000+ conditions where local access doesn't exist.
Open a procurement fileTender participation, direct procurement for ministries of health, NGO programmes and humanitarian supply corridors for high-burden disease therapies.
Open a procurement fileCTD/eCTD compilation, ICH long-term and accelerated stability, and BA/BE analytics that get you across the table at the regulatory authority, not stuck outside.
Open a procurement file